Eye involvement in children with primary focal segmental glomerulosclerosis

被引:0
|
作者
Fatih Ozaltin
Saskia Heeringa
Ceren Erdogan Poyraz
Yelda Bilginer
Sibel Kadayifcilar
Nesrin Besbas
Rezan Topaloglu
Seza Ozen
Friedhelm Hildebrandt
Aysin Bakkaloglu
机构
[1] Hacettepe University Faculty of Medicine,Unit of Nephrology, Department of Pediatrics
[2] University of Michigan,Department of Pediatrics
[3] Hacettepe University Faculty of Medicine,Department of Ophthalmology
来源
Pediatric Nephrology | 2008年 / 23卷
关键词
Childhood; Focal segmental glomerulosclerosis; Eye; Steroid-resistant nephrotic syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Distinct eye abnormalities have been described in children with nephrotic syndrome, particularly in diffuse mesangial sclerosis (i.e. Pierson syndrome). The aim of the study was to investigate whether there were any associated ocular anomalies in children with steroid-resistant nephrotic syndrome (SRNS), all of whom had revealed primary focal segmental glomerulosclerosis in biopsy. Thirty-three SRNS patients (16 male, 17 female) with a median age of 10.5 years (range 3–25 years) were enrolled in the study. Twenty steroid-sensitive nephrotic syndrome (SSNS) patients (ten male, ten female) with a median age of 8 years (range 3–15 years) served as controls. All SRNS patients were examined by mutational analysis for mutations in the NPHS2, WT1, and LAMB2 genes. Nine out of 33 SRNS patients (27.2%) showed various eye abnormalities. However, no abnormal ocular findings were detected in any of the SSNS patients. Abnormal eye findings detected in SRNS patients were anisometropic amblyopia (n = 4), Mittendorf’s dots (n = 4), myopic astigmatism (n = 3) and exotropia (n = 1). Macular pigment changes (n = 1), posterior subcapsular opacities (n = 1) and cataract (n = 1) were considered as steroid-induced side effects. In four patients, more than one eye abnormality was found. Mutational analysis for the NPHS2, WT1 and LAMB2 genes revealed disease-causing mutations in 24.2% of patients. Homozygous NPHS2 mutations were detected in five patients (15.1%), all of whom had parental consanguinity. In three patients (9%) from non-consanguineous parents, heterozygous de novo WT1 mutations were detected as disease-causing mutations. No LAMB2 mutation was detected in any patient. While four out of five (80%) patients with homozygous NPHS2 mutations showed at least one abnormal ocular finding (i.e. Mittendorf’s dot or anisometric amblyopia), none of the patients with a WT1 mutation had ocular involvement. In conclusion, ocular involvement may accompany SRNS caused by primary focal segmental glomerulosclerosis (FSGS). Ophthalmologic evaluation at the time of diagnosis might be beneficial to characterize further the spectrum of this possible association.
引用
收藏
页码:421 / 427
页数:6
相关论文
共 50 条
  • [41] Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis
    Alexopoulos, E
    Stangou, M
    Papagianni, A
    Pantzaki, A
    Papadimitriou, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (09) : 1348 - 1356
  • [42] Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis
    Abrantes, Marcelo M.
    Cardoso, Luis Sergio B.
    Lima, Eleonora M.
    Silva, Jose M. Penido
    Diniz, Jose S.
    Bambirra, Eduardo A.
    Oliveira, Eduardo A.
    PEDIATRIC NEPHROLOGY, 2006, 21 (07) : 1003 - 1012
  • [43] Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis
    Marcelo M. Abrantes
    Luis Sergio B. Cardoso
    Eleonora M. Lima
    José M. Penido Silva
    José S. Diniz
    Eduardo A. Bambirra
    Eduardo A. Oliveira
    Pediatric Nephrology, 2006, 21 : 1003 - 1012
  • [44] Clinical Significance of Urinary Biomarkers in Patients With Primary Focal Segmental Glomerulosclerosis
    Zhang, Qingyan
    Jiang, Chunming
    Tang, Tianfeng
    Wang, Hengjin
    Xia, Yangyang
    Shao, Qiuyuan
    Zhang, Miao
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2018, 355 (04) : 314 - 321
  • [45] Kartagener Syndrome With Focal Segmental Glomerulosclerosis
    Momeni, Ali
    Doroushi, Behzad
    Taheri, Nadia
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (06) : 499 - 501
  • [46] Galactose treatment in focal segmental glomerulosclerosis
    Howard Trachtman
    Virginia J. Savin
    Pediatric Nephrology, 2014, 29 : 931 - 931
  • [47] Oxidative injury in focal segmental glomerulosclerosis
    Chan, James C. M.
    ASIAN BIOMEDICINE, 2008, 2 (01) : 19 - 26
  • [48] Syphilis masquerading as focal segmental glomerulosclerosis
    Hartley, A. J.
    Rajakariar, R.
    Sheaff, M.
    Buckland, M.
    Goh, B.
    O'Connell, R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (07) : 529 - 531
  • [49] Mechanisms of Disease: focal segmental glomerulosclerosis
    Meyrier, A
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2005, 1 (01): : 44 - 54
  • [50] Microarray analysis of focal segmental glomerulosclerosis
    Schwab, K
    Witte, DP
    Aronow, BJ
    Devarajan, P
    Potter, SS
    Patterson, LT
    AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (04) : 438 - 447